Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
45°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Alector, Inc.
Alector to Participate in Upcoming Healthcare Conferences
February 28, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 27, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
February 20, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
February 08, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
GSK
FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
February 07, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
GSK
Alector Announces Closing of Public Offering
January 19, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Announces Pricing of Public Offering of Common Stock
January 17, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Announces Proposed Public Offering of Common Stock
January 16, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs
November 28, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in the Stifel Healthcare Conference
November 08, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update
November 07, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
October 27, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
GSK
Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
September 07, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ABBV
ALEC
Alector to Participate in Upcoming Healthcare Conferences
August 31, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Second Quarter 2023 Financial Results and Provides Business Update
August 03, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Host Mid-Year Earnings Conference Call
July 27, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
June 06, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports First Quarter 2023 Financial Results and Provides Business Update
May 04, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in the BofA Securities 2023 Healthcare Conference
May 02, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in Upcoming Healthcare Conferences
March 01, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
February 28, 2023
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 08, 2022
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Presents Results from First-in-Human Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases
November 29, 2022
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Third Quarter 2022 Financial Results and Provides Business Update
November 08, 2022
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in Upcoming Healthcare Conferences
November 07, 2022
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 03, 2022
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Announces Promotion of Clare Hunt to Chief People Officer
October 13, 2022
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 06, 2022
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.